Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gurevich

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Bioinformatics and Biology Insights|April 6, 2023
Normalization of Large-Scale Transcriptome Data Using Heuristic MethodsArthur Yosef, Eli Shnaider, Moti Schneider, et al.
CNS Neuroscience & Therapeutics|January 10, 2018
Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairmentsMichael Gurevich, Roy Waknin, Evan Stone, et al.
Neurorehabilitation|August 17, 2013
Do motor impairments detected on onset of multiple sclerosis suggest an early second attack? A prospective studyAlon Kalron, Zeevi Dvir, Michael Gurevich, et al.
International Journal of Molecular Sciences|November 27, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side EffectsMichael Gurevich, Rina Zilkha-Falb, Joab Chapman, et al.
Investigative Ophthalmology & Visual Science|January 17, 2015
The role of B cells in the early onset of the first demyelinating event of acute optic neuritisAnna Feldman, Michael Gurevich, Ruth Huna-Baron, et al.
Neuroscience|September 23, 2017
Prickle1 as positive regulator of oligodendrocyte differentiationRina Zilkha-Falb, Michael Gurevich, Erez Hanael, et al.
Scientific Reports|February 14, 2026
Myelin-specific IL2 + T-cells are associated with last occurring relapse severity in relapsing-remitting multiple sclerosisRina Zilkha-Falb, Tali Drori, Katya Shwartz, et al.
Human Molecular Genetics|June 17, 2011
Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissionsTamir Tuller, Shimshi Atar, Eytan Ruppin, et al.
Annals of Neurology|March 3, 2004
Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activityAnat Achiron, Michael Gurevich, Nir Friedman, et al.
Multiple Sclerosis and Related Disorders|April 6, 2019
Acute effects of aerobic intensities on the cytokine response in women with mild multiple sclerosisShani Berkowitz, Anat Achiron, Michael Gurevich, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Bioinformatics and Biology Insights|April 6, 2023
Normalization of Large-Scale Transcriptome Data Using Heuristic MethodsArthur Yosef, Eli Shnaider, Moti Schneider, et al.
CNS Neuroscience & Therapeutics|January 10, 2018
Fingolimod-improved axonal and myelin integrity of white matter tracts associated with multiple sclerosis-related functional impairmentsMichael Gurevich, Roy Waknin, Evan Stone, et al.
Neurorehabilitation|August 17, 2013
Do motor impairments detected on onset of multiple sclerosis suggest an early second attack? A prospective studyAlon Kalron, Zeevi Dvir, Michael Gurevich, et al.
International Journal of Molecular Sciences|November 27, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side EffectsMichael Gurevich, Rina Zilkha-Falb, Joab Chapman, et al.
Investigative Ophthalmology & Visual Science|January 17, 2015
The role of B cells in the early onset of the first demyelinating event of acute optic neuritisAnna Feldman, Michael Gurevich, Ruth Huna-Baron, et al.
Neuroscience|September 23, 2017
Prickle1 as positive regulator of oligodendrocyte differentiationRina Zilkha-Falb, Michael Gurevich, Erez Hanael, et al.
Scientific Reports|February 14, 2026
Myelin-specific IL2 + T-cells are associated with last occurring relapse severity in relapsing-remitting multiple sclerosisRina Zilkha-Falb, Tali Drori, Katya Shwartz, et al.
Human Molecular Genetics|June 17, 2011
Global map of physical interactions among differentially expressed genes in multiple sclerosis relapses and remissionsTamir Tuller, Shimshi Atar, Eytan Ruppin, et al.
Annals of Neurology|March 3, 2004
Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activityAnat Achiron, Michael Gurevich, Nir Friedman, et al.
Multiple Sclerosis and Related Disorders|April 6, 2019
Acute effects of aerobic intensities on the cytokine response in women with mild multiple sclerosisShani Berkowitz, Anat Achiron, Michael Gurevich, et al.
Pageof 10